Irinotecan hydrochloride
HealthData.Gov
Updated Mar 24, 2026
About this dataset
ONIVYDE is a prescription injectable drug containing irinotecan hydrochloride, a topoisomerase inhibitor used intravenously to treat certain cancers. It comes as a liposomal powder for solution, manufactured by Ipsen Biopharmaceuticals, Inc., and approved under NDA207793. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Irinotecan hydrochloride
Access the FDA dataset for Irinotecan hydrochloride β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025